让癌症医生参与非标签药物临床试验:以人为中心的设计方法
Maren C Parsell1,2, Morgan N Greenleaf1,2,3, Greeshma G Kombara2,4
1Georgia Clinical and Translational Science Alliance, Emory University School of Medicine, Emory University, Atlanta, GA, United States.
JMIR formative research
|February 15, 2024
概括
以人为中心的设计 (HCD) 在使用非标签药物 (OLD) 的癌症临床试验中有效地识别了医生使用非标签药物的障碍. 这种方法产生了三个支持资源概念,以改善医生参与OLD临床试验.
科学领域:
- 在瘤学瘤学.
- 临床试验设计 临床试验设计
- 以人为中心的设计
背景情况:
- 以人为中心的设计 (HCD) 提供了对临床试验设计中利益相关者的需求和挑战的见解.
- 医生在癌症治疗和临床试验中使用非标签药物 (OLD) 存在障碍.
- 对于临床试验设计,HCD没有被广泛教授,缺乏实际指导.
研究的目的:
- 为了证明应用HCD来为医生创造支持资源的可行性.
- 解决医生在涉及OLD的癌症临床试验中面临的障碍.
- 通过HCD.改善临床试验支持资源的设计.
主要方法:
- 应用HCD开发用于OLD临床试验的支持概念.
- 与15名癌症护理医生进行半结构面试,以确定障碍.
- 利用亲和力映射,主题分析和基于Web的共同设计会议,以精细化和优先考虑想法.
主要成果:
- HCD揭示了招聘挑战,没有数据处方的低意愿和耻辱等障碍.
- 息治疗医生是唯一自认的经常处方OLD的医生.
- 产生了150多个想法,并将它们精制成3个最终概念,以促进医生参与OLD临床试验.
结论:
- 参与性HCD方法为临床试验支持资源产生了3个概念.
- HCD有助于识别,参与和将医生观点纳入试验设计.
- 该研究强调了HCD在改善癌症临床试验设计方面的潜力,并倡导其采用和培训.
相关概念视频
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Nursing Ethical Principles II
973
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
973
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K


